Trial intelligence / Profile preview

Phase II BEBT-109 in EGFR exon 20 insertion mutant NSCLC

ChiCTR2600124385Phase 2Completed

Sponsor

Guangdong Provincial People's Hospital

Start

May 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1